Rebound hypergastrinemia after cessation of a somatostatin analogue (SMS 201-995) in malignant gastrinoma.
Buck, M
Rebound hypergastrinemia after cessation of a somatostatin analogue (SMS 201-995) in malignant gastrinoma. [electronic resource] - The American journal of medicine May 1987 - 92-5 p. digital
Publication Type: Case Reports; Journal Article
0002-9343
10.1016/0002-9343(87)90433-5 doi
Gastrins--blood
Humans
Liver Neoplasms--diagnostic imaging
Male
Middle Aged
Octreotide
Pancreatic Neoplasms--drug therapy
Radionuclide Imaging
Somatostatin--administration & dosage
Zollinger-Ellison Syndrome--drug therapy
Rebound hypergastrinemia after cessation of a somatostatin analogue (SMS 201-995) in malignant gastrinoma. [electronic resource] - The American journal of medicine May 1987 - 92-5 p. digital
Publication Type: Case Reports; Journal Article
0002-9343
10.1016/0002-9343(87)90433-5 doi
Gastrins--blood
Humans
Liver Neoplasms--diagnostic imaging
Male
Middle Aged
Octreotide
Pancreatic Neoplasms--drug therapy
Radionuclide Imaging
Somatostatin--administration & dosage
Zollinger-Ellison Syndrome--drug therapy